Prognostic studies in patients with high-risk primary breast cancer (HRPBC) receiving high-dose chemotherapy (HDC)

por Nieto, Y
Publicado 2005

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients trea...

por Nieto, Y, Woods, J, Nawaz, F, Baron, A, Jones, R B, Shpall, E J, Nawaz, S
Publicado 2007

Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines

por Valdez, B C, Zander, A R, Song, G, Murray, D, Nieto, Y, Li, Y, Champlin, R E, Andersson, B S
Publicado 2014

Romidepsin targets multiple survival signaling pathways in malignant T cells

por Valdez, B C, Brammer, J E, Li, Y, Murray, D, Liu, Y, Hosing, C, Nieto, Y, Champlin, R E, Andersson, B S
Publicado 2015

P1376: LENALIDOMIDE–BASED MAINTENANCE AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK MULTIPLE MYELOMA

por Pasvolsky, O., Milton, D., Rauf, M., Tanner, M., Bashir, Q., Srour, S., Saini, N., Ramdial, J., Nieto, Y., Lee, H., Patel, K., Kebriaei, P., Thomas, S., Weber, D., Orlowski, R., Shpall, E., Champlin, R., Qazilbash, M.
Publicado 2022